Description
MEXAXON-S 1.5 contains Ceftriaxone 1000 mg & Sulbactam 500 mg Injection in a 1 VIAL × 10 ML pack. Ceftriaxone is a cephalosporin antibiotic that works against susceptible bacteria, while Sulbactam helps inhibit certain beta-lactamase enzymes that can reduce the effectiveness of some beta-lactam antibiotics.
This combination may be prescribed for selected serious bacterial infections when appropriate. You can also explore the MedHexa Pharma Products range for other pharmaceutical formulations.
Therapeutic Segment
Antibiotic | Anti-Infective | Cephalosporin | Injectable Antibiotic
Uses of MEXAXON-S 1.5
MEXAXON-S 1.5 may be prescribed for selected bacterial infections when the causative organisms are susceptible to the combination.
It may be used in the management of:
- Urinary tract infections (UTIs)
- Respiratory tract infections (RTIs)
- Endocarditis caused by susceptible bacteria
- Selected nosocomial or hospital-acquired infections
- Other serious bacterial infections as determined by a healthcare professional
However, the exact indication depends on the type of infection, bacterial susceptibility and the patient’s clinical condition. Therefore, this antibiotic should be used only under appropriate medical supervision.
Key Benefits of MEXAXON-S 1.5
MEXAXON-S 1.5 combines Ceftriaxone and Sulbactam to provide antibacterial activity against susceptible organisms.
- Contains Ceftriaxone 1000 mg
- Contains Sulbactam 500 mg
- Provides antibacterial activity against susceptible bacteria
- May be prescribed for selected urinary tract infections
- May support treatment of certain respiratory tract infections
- May be used for selected serious bacterial infections
- Sulbactam helps inhibit certain beta-lactamase enzymes
- Injectable formulation for use under professional medical supervision
Furthermore, the Sulbactam component can help protect Ceftriaxone from certain beta-lactamase enzymes. As a result, the combination may provide useful antibacterial coverage against susceptible organisms that produce relevant enzymes.
How the Combination Works
Ceftriaxone belongs to the third-generation cephalosporin group of antibiotics. It interferes with bacterial cell-wall formation, which can lead to the death of susceptible bacteria.
Meanwhile, Sulbactam acts as a beta-lactamase inhibitor. Certain bacteria produce beta-lactamase enzymes that can break down beta-lactam antibiotics. Sulbactam can inhibit some of these enzymes and may therefore help preserve the antibacterial activity of Ceftriaxone.
Together, the two components may provide antibacterial activity against selected susceptible organisms. However, treatment should depend on the identified or suspected bacteria and the healthcare professional’s assessment.
MEXAXON-S 1.5 Side Effects
Like other injectable antibiotics, this combination may cause side effects in some patients.
Possible effects include:
- Pain or discomfort at the injection site
- Diarrhea
- Nausea
- Vomiting
- Abdominal discomfort
- Headache
- Skin rash
- Changes in liver enzyme levels
Most side effects are manageable; however, serious reactions can occur rarely.
Seek immediate medical attention if you experience difficulty breathing, facial or throat swelling, severe skin reactions or severe or persistent diarrhea.
MEXAXON-S 1.5 Safety Information
MEXAXON-S 1.5 should be administered only by a qualified healthcare professional.
Before treatment, tell your doctor if you:
- Have an allergy to Ceftriaxone, Sulbactam, cephalosporins, penicillins or other beta-lactam antibiotics
- Have kidney or liver problems
- Have a history of gastrointestinal disease, particularly colitis
- Have previously experienced a serious reaction to antibiotics
- Are pregnant or breastfeeding
- Take other prescription or over-the-counter medicines
In addition, inform your healthcare professional about all medicines and supplements you currently use.
Antibiotics should not be used for viral infections such as the common cold or influenza. Also, do not stop antibiotic treatment early unless your healthcare professional advises you to do so.
For additional information about Ceftriaxone, refer to DailyMed Ceftriaxone Drug Information.
Dosage and Administration
MEXAXON-S 1.5 should be administered only according to the prescription and instructions of a qualified healthcare professional.
- The injection should be prepared and administered by trained medical personnel.
- The route of administration should follow the approved product instructions and prescription.
- The dose depends on the type and severity of infection, age, body weight and clinical condition.
- Do not self-administer the injection.
- Do not change the prescribed dose or treatment duration without medical advice.
- Complete the prescribed antibiotic treatment unless your healthcare professional advises otherwise.
The healthcare professional may consider laboratory results, bacterial susceptibility and the patient’s clinical response when determining the appropriate treatment.
Ceftriaxone 1000 mg & Sulbactam 500 mg Injection Information
MEXAXON-S 1.5 combines Ceftriaxone 1000 mg and Sulbactam 500 mg in injectable form.
Ceftriaxone provides antibacterial activity by interfering with bacterial cell-wall synthesis. Sulbactam, meanwhile, inhibits certain beta-lactamase enzymes. Therefore, the combination may help manage selected infections caused by susceptible bacteria when prescribed appropriately.
Because antibiotic selection depends on the causative organism and its susceptibility, healthcare professionals should determine whether this combination is suitable for the individual patient.
Storage
- Store MEXAXON-S 1.5 according to the conditions stated on the product label.
- Keep the vial in its original packaging until use.
- Protect from excessive heat and moisture.
- Keep away from direct sunlight.
- Keep out of reach of children.
- Do not use the product after the expiry date.
- Follow the specific storage instructions provided with the product.
